Carlisle Companies Inc Reports Positive HEMGENIX Study Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10 Dec 25
Source: Businesswire
Carlisle Companies Inc's stock rose by 3.03% and reached a 20-day high, reflecting strong investor interest.
The recent HOPE-B study results for HEMGENIX showed that 94% of patients remained free from continuous treatment five years after a single infusion, highlighting the therapy's long-term efficacy and safety. This positive outcome is expected to enhance market demand for HEMGENIX.
The sustained factor IX activity levels and significant reduction in bleeding rates further support the therapy's potential, which may lead to increased adoption and revenue growth for Carlisle Companies Inc in the future.
Analyst Views on CSL
Wall Street analysts forecast CSL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSL is 385.33 USD with a low forecast of 356.00 USD and a high forecast of 400.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 341.010
Low
356.00
Averages
385.33
High
400.00
Current: 341.010
Low
356.00
Averages
385.33
High
400.00
About CSL
Carlisle Companies Incorporated is a manufacturer and supplier of building envelope products and solutions that enable energy efficiency in buildings. Its segments include Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). The CCM segment produces a complete line of energy-efficient single-ply roofing products and warranted roof systems and accessories for the commercial building industry, including ethylene propylene diene monomer (EPDM), thermoplastic polyolefin (TPO) and polyvinyl chloride (PVC) membrane, polyisocyanurate (polyiso) insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings. CWT segment produces building envelope solutions that drive energy efficiency and sustainability in commercial and residential applications. Its products include waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
